Apixaban, Warfarin Equally Safe, Study FindsA study found that apixaban is a safe alternative to VKAs for ablation of atrial fibrillation.
Xarelto reduces hospital stays: StudyHospital stays were shorter for patients treated with Xarelto (rivaroxaban) in a new study, compared to those receiving standard anticoagulants.
Oral anticoagulation may not help all AF patientsNew study finds that AF patients under 65 years of age but with a CHA2DS2-VASc score of 1 are unlikely to benefit from anticoagulation therapy.